| abstract |
The present invention relates to secondary catecholamine derivatives as well as pharmaceutical compositions containing these compounds. In addition, the invention relates to the use of secondary catecholamine derivatives, as well as physiologically acceptable salts thereof, and also to pharmaceutical compositions containing these compounds, in combination with enzyme inhibitors, for the treatment of dopamine deficiency diseases or diseases which are based on impaired tyrosine transport or impaired tyrosine decarboxylase, as well as other disorders. |